Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liposomal paclitaxel
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: NJLYSK-LPS-2013-01, NCT01994031
Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 18 to less than 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: LY-TM-LPS-2014-02, NCT02142790
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CSMECS 01, LYC01, NCT01998347
Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LPS-01-2013, NCT02163291
Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: LPS-GC-01-2008, NCT00639522
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BT-IST-NSCLC-053, NCT01393080
Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 64
Sponsor: Pharmaceutical / Industry
Protocol IDs: LY-TM-LPS-2014-01, NCT02142010
Start Over